These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 17561874

  • 1. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
    Aweeka FT, Kang M, Yu JY, Lizak P, Alston B, Chung RT, AIDS Clinical Trials Group 5092s Study Team.
    HIV Med; 2007 Jul; 8(5):288-94. PubMed ID: 17561874
    [Abstract] [Full Text] [Related]

  • 2. Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study.
    Rodriguez-Torres M, Torriani FJ, Soriano V, Borucki MJ, Lissen E, Sulkowski M, Dieterich D, Wang K, Gries JM, Hoggard PG, Back D.
    Antimicrob Agents Chemother; 2005 Oct; 49(10):3997-4008. PubMed ID: 16189072
    [Abstract] [Full Text] [Related]

  • 3. Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons.
    Alvarez D, Dieterich DT, Brau N, Moorehead L, Ball L, Sulkowski MS.
    J Viral Hepat; 2006 Oct; 13(10):683-9. PubMed ID: 16970600
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.
    Panhard X, Legrand M, Taburet AM, Diquet B, Goujard C, Mentré F, Cophar 1 - ANRS 102 Study Group.
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1019-29. PubMed ID: 17694300
    [Abstract] [Full Text] [Related]

  • 6. Effect of ribavirin on zidovudine efficacy and toxicity in vitro: a concentration-dependent interaction.
    Sim SM, Hoggard PG, Sales SD, Phiboonbanakit D, Hart CA, Back DJ.
    AIDS Res Hum Retroviruses; 1998 Dec 20; 14(18):1661-7. PubMed ID: 9870320
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage.
    De Franceschi L, Fattovich G, Turrini F, Ayi K, Brugnara C, Manzato F, Noventa F, Stanzial AM, Solero P, Corrocher R.
    Hepatology; 2000 Apr 20; 31(4):997-1004. PubMed ID: 10733558
    [Abstract] [Full Text] [Related]

  • 9. Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells.
    Robbins BL, Rodman J, McDonald C, Srinivas RV, Flynn PM, Fridland A.
    Antimicrob Agents Chemother; 1994 Jan 20; 38(1):115-21. PubMed ID: 7511360
    [Abstract] [Full Text] [Related]

  • 10. Measurement of ribavirin plasma concentrations by high-performance liquid chromatography using a novel solid-phase extraction method in patients treated for chronic hepatitis C.
    Morello J, Rodríguez-Nóvoa S, Cantillano AL, González-Pardo G, Jiménez I, Soriano V.
    Ther Drug Monit; 2007 Dec 20; 29(6):802-6. PubMed ID: 18043479
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
    Brockmeyer NH, Tillmann I, Mertins L, Barthel B, Goos M.
    Eur J Med Res; 1997 Sep 29; 2(9):377-83. PubMed ID: 9300934
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of oral zidovudine administered during labour: a preliminary study.
    Mirochnick M, Rodman JH, Robbins BL, Fridland A, Gandía J, Hitti J, Bardeguez A, Rathore MH, Gonzalez Garcia A, Cababasay M, Samson P, Mofenson L, Bryson YJ, Dorenbaum A.
    HIV Med; 2007 Oct 29; 8(7):451-6. PubMed ID: 17760737
    [Abstract] [Full Text] [Related]

  • 15. In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1.
    Margot NA, Miller MD.
    Antivir Ther; 2005 Oct 29; 10(2):343-8. PubMed ID: 15865229
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors.
    von Hentig N, Babacan E, Lennemann T, Knecht G, Carlebach A, Harder S, Staszewski S, Haberl A.
    J Antimicrob Chemother; 2008 Sep 29; 62(3):579-82. PubMed ID: 18477709
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F, Lapidus N, Bedossa P, De Boever CM, Perronne C, Halfon P, Pol S, Carrat F, Cacoub P, French National Agency for Research on AIDS, Viral Hepatitis-HC02-Ribavic Study Team.
    Clin Infect Dis; 2008 Mar 01; 46(5):768-74. PubMed ID: 18248298
    [Abstract] [Full Text] [Related]

  • 20. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.
    Clin Infect Dis; 2008 Feb 15; 46(4):611-21. PubMed ID: 18197758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.